Last reviewed · How we verify
INTERCOAT administration
At a glance
| Generic name | INTERCOAT administration |
|---|---|
| Also known as | INTERCOAT |
| Sponsor | Carmel Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Efficiency of INTERCOAT (Oxiplex/AP Gel) in Preventing Intrauterine Adhesion Formation in Hysteroscopic Surgery (NA)
- Efficiency of Intercoat (Oxiplex/AP Gel)in Decreasing Intrauterine Adhesions (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- INTERCOAT administration CI brief — competitive landscape report
- INTERCOAT administration updates RSS · CI watch RSS
- Carmel Medical Center portfolio CI